Table 3.
Variables | Short surviving group (228, 46.4%) | Long surviving group (n = 263, 53.6%) | P |
---|---|---|---|
N (%) or median (IQR) | |||
Total number of deaths | 228 (100.0) | 56 (21.3) | < 0.0001 |
Infection (any type) | 33 (14.5) | 5 (1.9) | < 0.0001 |
Cardiac | 28 (12.3) | 4 (1.5) | < 0.0001 |
28 (12.3) | 0 (–) | < 0.0001 | |
Recurrence HCC | 28 (12.3) | 4 (1.5) | < 0.0001 |
Recurrence HCV | 22 (9.6) | 8 (3.0) | 0.002 |
De novo tumor | 20 (8.8) | 10 (3.8) | 0.02 |
PNF | 14 (6.1) | 0 (–) | < 0.0001 |
Brain | 10 (4.4) | 0 (–) | 0.0004 |
Gastrointestinal hemorrhage | 10 (4.4) | 0 (–) | 0.0004 |
Chronic rejection | 8 (3.5) | 6 (2.3) | 0.43 |
Recurrence other disease | 8 (3.5) | 6 (2.3) | 0.43 |
Biliary complication | 5 (2.2) | 2 (0.8) | 0.26 |
Vascular thrombosis | 5 (2.2) | 0 (–) | 0.02 |
Intraoperative death | 3 (1.3) | 0 (–) | 0.10 |
Recurrence HBV | 3 (1.3) | 2 (0.8) | 0.67 |
Suicide | 3 (1.3) | 0 (–) | 0.10 |
Extreme old age | 0 (–) | 5 (1.9) | 0.06 |
Other | 2 (0.8) | 6 (2.3) | 0.30 |
N number, IQR interquartile ranges, PDF primary dysfunction, HCC hepatocellular carcinoma, HCV hepatitis C virus, PNF primary non-function, HBV hepatitis B virus